That means even if you're taking a GLP-1 medication for diabetes or weight management, the body's response, like insulin release, may be blunted
Rival Eli Lilly first won FDA approval of its similar GLP-1 diabetes drug, tirzepatide, in the United States in 2022 and sells it under the brand name Mounjaro
We have worked closely with the FDA to resolve their questions expeditiously and are pleased that the clinical hold on our DM1 program in the United States has been lifted, PepGen president and CEO James McArthur said in Thursdays press release
Favorece la quema de grasas durante el ejercicio aerbico o de fuerza
These concerns were amplified when Novo Nordisk issued a public warning about the "significant dangers" associated with illegitimate compounded semaglutide products, some of which were found to contain impurities, harmful ingredients, or incorrect dosages